XML 50 R44.htm IDEA: XBRL DOCUMENT v3.26.1
Commitments and Contingencies - Additional Information (Details)
6 Months Ended
Jun. 30, 2026
USD ($)
Action
Jul. 31, 2025
USD ($)
Loss Contingencies [Line Items]    
Number of actions filed | Action 2  
Legal proceedings allegations The Complaints allege that the defendants filed or caused to be filed a materially incomplete and misleading registration statement with the SEC and asserts claims under New York common law for negligent misrepresentation and concealment and negligence. In addition, the Company and its board of directors have received five additional demands from purported stockholders seeking additional disclosures in the registration statement (collectively, the “Demands”).  
Smith v. Ikena Oncology, Inc.    
Loss Contingencies [Line Items]    
Lawsuit filing date Jun. 12, 2025  
Kent v. Ikena Oncology, Inc.    
Loss Contingencies [Line Items]    
Lawsuit filing date Jun. 13, 2025  
Hutchmed Agreement | Maximum    
Loss Contingencies [Line Items]    
License agreement milestone payment per licensed product upon achievement of development and regulatory milestones   $ 92,500,000
Milestone payment per licensed compound upon achievement of worldwide aggregate cumulative net sales milestones   $ 135,000,000
Indemnification Agreements    
Loss Contingencies [Line Items]    
Accrued liabilities of claims $ 0